Apo-lipoproteic pattern in type I complicated diabetes (I.D.D.) with microangiopathy and with no clinico-instrumental signs of macroangiopathy.--Note II.
No significant changes of C, C-HDL, C-VLDL, C-LDL, C-HDL/C, Tg, Tg-VLDL and apo B were evidenced in 12 compensated microangiopathic I.D.D. in comparison with 20 healthy controls. Instead the analysis of the data obtained comparing the same I.D.D. with 10 decompensated microangiopathic I.D.D., selected with the same criteria, has pointed out no significant changes between the two groups as regards C, C-HDL, C-VLDL, C-LDL, C-HDL/C and a statistically significant increase of Tg and Tg-VLDL in the 10 decompensated I.D.D.. Our results agree with those of Nikkila and we think we can conclude that it is not possible to evidence a characteristic lipidic or lipoproteic "marker" in compensated microangiopathic I.D.D.
D000328:Adult; D001053:Apolipoproteins / Q000097:blood*; D002784:Cholesterol / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000097:blood*; D003925:Diabetic Angiopathies / Q000097:blood*; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged
D001053:Apolipoproteins; D008074:Lipoproteins; D002784:Cholesterol